Gene · 5216
Papers2,319
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,319
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Adverse developmental impacts in progeny of zebrafish exposed to the agricultural herbicide atrazine during embryogenesis. | Environ Int | 2023 | 37774458 | PubTator, text mining | PubMed |
| A large-scale targeted proteomics of serum and tissue shows the utility of classifying high grade and low grade meningioma tumors. | Clin Proteomics | 2023 | 37770851 | PubTator, text mining | PubMed |
| Lipopolysaccharide triggers exacerbated microglial activation, excessive cytokine release and behavioural disturbances in mice with truncated Fused-in-Sarcoma Protein (FUS). | Brain Behav Immun Health | 2023 | 37767237 | PubTator, text mining | PubMed |
| A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer. | Mol Oncol | 2023 | 37753805 | PubTator, text mining | PubMed |
| Functional and structural insights into the multi-step activation and catalytic mechanism of bacterial ExoY nucleotidyl cyclase toxins bound to actin-profilin. | PLoS Pathog | 2023 | 37747912 | PubTator, text mining | PubMed |
| Genetic Screening of ZNF687 and PFN1 in a Paget's Disease of Bone Cohort Indicates an Important Role for the Nuclear Localization Signal of ZNF687. | Calcif Tissue Int | 2023 | 37728743 | PubTator, text mining | PubMed |
| Unraveling the impact of disrupted nucleocytoplasmic transport systems in C9orf72-associated ALS. | Front Cell Neurosci | 2023 | 37720544 | PubTator, text mining | PubMed |
| Rosuvastatin effects on the HDL proteome in hyperlipidemic patients. | Acta Pharm | 2023 | 37708957 | PubTator, text mining | PubMed |
| ATP induces folding of ALS-causing C71G-hPFN1 and nascent hSOD1. | Commun Chem | 2023 | 37670116 | PubTator, text mining | PubMed |
| iPSC motor neurons, but not other derived cell types, capture gene expression changes in postmortem sporadic ALS motor neurons. | Cell Rep | 2023 | 37651231 | PubTator, text mining | PubMed |
| A unique cytotoxic CD4+ T cell-signature defines critical COVID-19. | Clin Transl Immunology | 2023 | 37645435 | PubTator, text mining | PubMed |
| Exosomes are involved in the intercellular transfer of rapamycin resistance in the breast cancer cells. | Bioimpacts | 2023 | 37645026 | PubTator, text mining | PubMed |
| Current insights in the molecular genetic pathogenesis of amyotrophic lateral sclerosis. | Front Neurosci | 2023 | 37638324 | PubTator, text mining | PubMed |
| The Proteome Profile of Olfactory Ecto-Mesenchymal Stem Cells-Derived from Patients with Familial Alzheimer's Disease Reveals New Insights for AD Study. | Int J Mol Sci | 2023 | 37628788 | PubTator, text mining | PubMed |
| miRNA profiling as a complementary diagnostic tool for amyotrophic lateral sclerosis. | Sci Rep | 2023 | 37612427 | PubTator, text mining | PubMed |
| The actin binding protein profilin 1 is critical for mitochondria function. | bioRxiv | 2023 | 37609280 | PubTator, text mining | PubMed |
| Correction to: Profilin-1 negatively controls osteoclast migration by suppressing the protrusive structures based on branched actin filaments. | J Bone Miner Metab | 2023 | 37597053 | PubTator, text mining | PubMed |
| ALKBH5 inhibitors as a potential treatment strategy in heart failure-inferences from gene expression profiling. | Front Cardiovasc Med | 2023 | 37583580 | PubTator, text mining | PubMed |
| The identification of high-performing antibodies for Profilin-1 for use in Western blot, immunoprecipitation and immunofluorescence. | F1000Res | 2023 | 37576538 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Analysis of Bone Marrow and Plasma from Patients with Extramedullary Multiple Myeloma Identifies Distinct Protein and Metabolite Signatures. | Cancers (Basel) | 2023 | 37568580 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5216/papers?page=10